Journal of Laboratory Physicians
Home About us Ahead of print Current issue Back issues Subscribe Instructions Contact Login 
Wide layoutNarrow layoutPrint this page  Email this page Bookmark this page Small font size Default font size Increase font size 
 


 
ORIGINAL ARTICLE
Year : 2009  |  Volume : 1  |  Issue : 2  |  Page : 73-76 Table of Contents   

Acinetobacter septicemia in neonates admitted to intensive care units


1 Department of Microbiology, B.J. Medical College and Sassoon General Hospital, Pune, Maharashtra, India
2 Department of Microbiology, SKN Medical College and General Hospital, Pune, Maharashtra, India

Date of Web Publication5-Feb-2010

Correspondence Address:
Vrishali A Muley
Department of Microbiology, SKN Medical College and General Hospital, Pune, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-2727.59704

Rights and Permissions
   Abstract 

Background: Acinetobacter species are gaining importance as potential pathogens in neonatal septicemia because of their frequent isolation and multidrug resistance.
Aims and Objectives: The aim of the present study was to evaluate the role of Acinetobacter spp. as important pathogens in neonatal blood stream infection, to identify the associated risk factors, and to evaluate the drug sensitivity pattern.
Materials and Methods: Blood samples of infected neonates were studied bacteriologically. Cases of Acinetobacter septicemia were identified. Speciation of Acinetobacter species was done. Various risk factors were identified. The drug-sensitivity test was done.
Results: A total of 26 Acinetobacter septicemia cases were identified by blood culture. Acb complex strains predominated. Institutional birth and preterm birth were identified as the most frequent significant risk factors. 11.3% mortality rate was recorded. Acb complex strains exhibited a multi-drug resistant pattern. No carbapenem resistance was observed.
Conclusion: Acinetobacter should be added to the list of organisms causing severe nosocomial infection in neonatal intensive care units. Continuous bacteriological surveillance, implementation of infection control policies, careful disinfection of intensive care equipment, and rational antibiotic use are required for control of such infections.

Keywords: Acinetobacter septicemia, multi-drug resistance, neonates


How to cite this article:
Shete VB, Ghadage DP, Muley VA, Bhore AV. Acinetobacter septicemia in neonates admitted to intensive care units. J Lab Physicians 2009;1:73-6

How to cite this URL:
Shete VB, Ghadage DP, Muley VA, Bhore AV. Acinetobacter septicemia in neonates admitted to intensive care units. J Lab Physicians [serial online] 2009 [cited 2018 Dec 11];1:73-6. Available from: http://www.jlponline.org/text.asp?2009/1/2/73/59704


   Introduction Top


Acinetobacter , once considered as opportunistic pathogen of low virulence, has recently been emerged as an important nosocomial pathogen world over, mostly involving patients with impaired host defence, especially in intensive care units, neonatal units, and surgical wards. [1],[2]

Acinetobacter species are the second most commonly isolated nonfermenter in human specimens (Pseudomonas aeruginosa is the most common). [3] They rank fourth (after Pseudomonas aeruginosa, Staphylococcus aureus, and Klebsiella pneumoniae) among the most frequent hospital acquired infectious agents. [4]

Septicemia remains a significant cause of morbidity and mortality in the newborns, more so in the developing countries. [5] In India, according to National Neonatal Perinatal Database (NNPD) 2002-03, the incidence of neonatal septicemia has been reported to be 30/1000 live births. Along with other organisms such as E. coli, Klebsiella spp., Staphylococcus aureus, Pseudomonas spp., and  Salmonella More Details spp., Acinetobacter species are gaining importance as potential pathogens in neonatal septicemia because of their frequent isolation and multi-drug resistance. [6]

There are many studies documented wordwide in the literature, emphasizing the Acinetobacter as an important nosocomial agent of septicemia in neonatal intensive care units (NICU). [6],[7],[8],[9],[10],[11] Early diagnosis and appropriate antimicrobial therapy of septicemia are of utmost importance to prevent morbidity and mortality.

The present study highlights Acinetobacter spp. as important pathogens in neonatal blood stream infection . Identification of risk factors for Acinetobacter septicemia and evaluation of antimicrobial sensitivity results were the other objectives.


   Materials and Methods Top


The present study included a total of 240 cases of neonatal septicemia admitted to NICU. All clinical details of these patients were noted. Blood samples of these neonates were collected with strict aseptic precautions. These samples were processed by standard bacteriological procedure for the isolation of Acinetobacter species. [3]

Identification of Acinetobacter species was made on the basis of phenotypic criteria recommended by Gerner-Smidt. [12] (Gram staining, colony morphology, penicillin susceptibility, oxidase, catalase and urease activity, citrate reduction, gelatin hydrolysis, glucose and lactose fermentation, and growth at 37°C and 44°C).

Antimicrobial susceptibility testing was performed on Muller Hinton agar by disc diffusion method for the following antimicrobial agents according to the Clinical and Laboratory Standards Institutes guidelines (CLSI): [13] amikacin (30 µg), ampicillin (10 µg), cefotaxime (30 µg), ceftazidime (30 µg), ciprofloxacin (5 µg), gentamicin (10 µg), chloramphenicol (30 µg), co-trimoxazole (25 µg), imipenem (10 µg), and meropenem (10 µg).  Escherichia More Details coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 were used as quality control strains.

Statistical analysis was done to see the association between various risk factors and Acinetobacter septicemia.


   Results Top


A total of 26 Acinetobacter species were isolated from blood specimens of 26 septicemia neonates. Thus Acinetobacter constituted for 10.8% (26/240) of total cases of neonatal septicemia. Of these, 22 (84.6%) isolates were identified as Acb complex strains and 4 (15.4%) isolates as Acinetobacter lwoffi.

The various risk factors observed for Acinetobacter septicemia are displayed in [Table 1].

It is seen from [Table 1] that babies born in the hospitals and born before the term are comparatively at higher risk of acquiring Acinetobacter infection. A significant association was observed between the different risk factors such as hospital birth, preterm birth, birth weight <1500 g, hospitalization >7 days, and mechanical ventilation. Although utilization of CVC, incubation, and age ≤ 7 days are seen associated with Acinetobacter blood stream infection, their association was not proved statistically significant.

A total number of three babies died. The mortality rate was 11.3%. All these babies had grown Acb complex strains on blood culture.

The drug-sensitivity results are shown in [Table 2].

The multi-drug resistant pattern was observed with Acb complex strains. Merpoenem, imipenem, and amikacin are found to be the most effective drugs against Acb complex strains. A. lwoffii had shown comparatively sensitive pattern. All Acinetobacter strains showed 100% sensitivity to imipenem and meropenem.


   Discussion Top


Acinetobacter is an emerging important nosocomial pathogen, which particularly affects critically ill patients in intensive care units (ICUs), neurosurgery, burn, and haemodialysis units. [1]

Although classically described as nosocomial pathogen in adults, Acinetobacter is also an important pathogen in neonates hospitalized in ICUs. [14] Increasing rates of Acinetobacter infections may be due to lapses in infection- control practices. In these situations, "colonization pressure", which is a function of the proportion of patients already colonized or infected with Acinetobacter, can affect the likelihood of cross-transmission between patients. [15] Acinetobacter has been implicated in many outbreaks of neonatal sepsis in NICU. [7],[10],[16] The isolation rate of Acinetobacter species from blood samples of septicemic neonates in the Indian literature ranges from 8.3% to 15.2%. [6],[11],[17] In the present study, Acinetobacter contributed to 10.8% of total septicemia cases. Acb complex strain was the most predominant strain encountered in neonatal septicemia accounting for 84.6% of total cases of Acinetobacter septicemia.

The risk factors associated with nosocomial infections due to this microorganism include mechanical ventilation, surgery, and trauma. [15] Septicemia due to Acinetobacter spp. are common in babies with predisposing factors such as intravascular catheterization, endotracheal intubation, parenteral nutrition, broad spectrum antibiotic therapy, and artificial ventilation. [6]

In the present study, various risk factors identified for Acinetobacter septicemia are tabulated in [Table 1]. Institutional birth and preterm birth are identified as the most frequent risk factors. This might be because of multi-drug resistant strains jerking in the hospital environment. [11] We observed a significant association between Acinetobacter blood stream infection and following risk factors: Hospital birth, preterm birth, birth weight <1500 g, hospitalization >7 days, and mechanical ventilation. Denise von Dolinger de Brito et al.[15] had reported the similar findings.

In all the documented studies of Acinetobacter septicemias in neonates, the mortality rate ranges from 13.9% to 83%. [14],[18] We recorded 11.3% mortality (3-26) in the present study.

In recent years, multiple antibiotic-resistant Acinetobacter have been widely reported from ICUs. [1] Outbreaks due to multiple resistant strains have been difficult to control, especially in ICUs. It is documented that the prior use of third-generation cephalosporins (especially ceftazidime), fluoroquinolones, and carbapenems is associated with the subsequent development of MDR A. baumannii. [19]

Acb complex strains have exhibited the multi-drug resistant pattern in the present study. A. lwoffii strains have shown comparatively a sensitive pattern. Cephalosporin resistance is observed in 81-86% Acinetobacter strains. Mechanisms of acquiring resistance to cephalosporins and carbapenems described for A. baumannii are altered penicillin-binding proteins, the presence of metallo-beta lactamases, and the loss of porins. [15] However, no carbapenem resistance is encountered with the Acinetobacter strains in the current study.


   Conclusion Top


Acinetobacter should be added to the list of organisms causing severe nosocomial infection in neonatal intensive care units. Multi-drug resistant nosocomial Acinetobacter septicemia may cause severe clinical disease in neonates that is associated with a high mortality. [20] The increase in the infection rate due to a particular pathogen may be due to lapses in infection-control measures, resulting in an increase in cross-transmission between patients. Therefore, continuous bacteriological surveillance, implementation of infection control policies, careful disinfection of intensive care equipment, and rational antibiotic use are required to control such infections.

 
   References Top

1.Bergogne-Berezin E, Towner KJ. Acinetobacter species as nosocomial pathogens: Microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996;9:148-65.  Back to cited text no. 1      
2.Melamed R, Greenberg D, Porat N, Karplus M, Zmora E, Golan A, et al. Successful control of an Acinetobacter baumannii outbreak in a neonatal intensive care unit. J Hosp Infect 2003;53:31-8.  Back to cited text no. 2      
3.Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn Jr WC. Color Atlas and textbook of diagnostic microbiology. 5 th ed. Lippincott Williams and Wilkins; 1997. p. 253-320.  Back to cited text no. 3      
4.Aktas O, Ozbek A. Prevalence and in-vitro antimicrobial susceptibility patterns of acinetobacter strains isolated from patients in intensive care units. J Int Med Res 2003;31:272-80.  Back to cited text no. 4      
5.Khatua SP, Das AK, Chatterjee BD, Khatua S, Ghose B, Saha A. Neonatal septicaemia. Indian J Pediatr 1986;53:509-14.  Back to cited text no. 5      
6.Vinodkumar CS, Neelagund YF. Acinetobacter septicaemia in neonates. Indian J Med Microbiol 2004;22:71  Back to cited text no. 6  [PUBMED]  Medknow Journal  
7.Touati A, Achour W, Cherif A, Hmida HB, Afif FB, Jabnoun S, et al. Outbreak of Acinetobacter baumannii in a neonatal intensive care unit: Antimicrobial susceptibility and genotyping analysis. Ann Epidemiol 2009;19:372-8.  Back to cited text no. 7      
8.Jeena P, Thompson E, Nchabeleng M, Sturm A. Emergence of multi-drug-resistant Acinetobacter anitratus species in neonatal and paediatric intensive care units in a developing country: Concern about antimicrobial policies. Ann Trop Paediatr 2001;21:245-51.  Back to cited text no. 8      
9.Jarousha AA, El Qouqa IA, Jadba AE, Al Afifi AS. Acinetobacter baumannii infection in the neonatal intensive care unit. Iranian J Publ Health 2008;37:107-12.  Back to cited text no. 9      
10.Yhu-Chering SH, Wu LH, Leu TL, Hsieh HS, Wu-Shiun MD, Tung-Mei LC et al. Outbreak of Acinetobacter baumannii bacteraemia in a neonatal intensive care unit: Clinical implications and genotyping analysis. Pediatr Infect Dis J 2002;1:1105-9.   Back to cited text no. 10      
11.Arora U, Jaitwani J. Acinetobacter spp.: An emerging pathogen in neonatal septicaemia in Amritsar. Indian J Med Microbiol 2006;24:81.  Back to cited text no. 11      
12.Gerner-Smidt P, Tjernberg I, Ursing J. Reliability of phenotypic tests foridentification of Acinetobacter species. J Clin Microbiol 1991;29:277-82.  Back to cited text no. 12      
13.Clinical and Laboratory Standards Institutes 2004: Performancestandards for antimicrobial susceptibility testing; Fourteenth informational supplement M100-S14 Vol.24 No.1 Pennsylvania USA 2004.  Back to cited text no. 13      
14.McDonald LC, Walker M, Loretta C, Matthew A, Sonia M, Perry G, et al. Outbreak of Acinetobacter spp. bloodstream infections in a nursery associated with contaminated aerosols and air conditioners. Pediatr Infect Dis J 1998;17:716-22.   Back to cited text no. 14      
15.von Dolinger de Brito D, Oliveira EJ, Abdallah VO, da Costa Darini AL, Filho PP. An outbreak of Acinetobacter baumannii septicemia in a neonatal intensive care unit of a university hospital in Brazil. Braz J Infect Dis 2005;9:301-9.  Back to cited text no. 15      
16.de Brito VD, Oliveira EJ, da Costa Darini AL, Abdallah VO, Gontijo-Filho PP. Nosocomial outbreaks due to Pseudomonas aeruginosa and Acinetobacter baumannii in a Neonatal Intensive Care Unit (NICU) of the Uberlândia Federal University Hospital. Braz J Microbiol 2003;34:27-8.   Back to cited text no. 16      
17.Mondal GP, Raghvan M, Vishnu B, Srinivasan S. Neonatal septicemia among inborn and outborn babies in a referal hospital. Indian J Pediatr 1991;58:529-33.  Back to cited text no. 17      
18.Pillay T, Pillay DG, Adhikari M, Pillay A, Sturm AW. An outbreak of neonatal infection with Acinetobacter linked to contaminated suction catheters. J Hosp Infect 1999;43:299-304.   Back to cited text no. 18      
19.Wang SH, Sheng WH, Chang YY, Wang LH, Lin HC, Chen ML, et al. Healthcare associated outbreak due to pan-drug resistant Acinetobacter baumannii in a surgical intensive care unit. J Hosp Infect 2003;53:97-102.   Back to cited text no. 19      
20.Cisneros JM, Reyes MJ, Pachon J, Becerril B, Caballero FJ, Garcia-Garmendia JL, et al. Bacteremia due to Acinetobacter baumannii: Epidemiology, clinical findings, and prognostic features. Clin Infect Dis 1996;22:1026-32.  Back to cited text no. 20      



 
 
    Tables

  [Table 1], [Table 2]



 

Top
 
  Search
 
  
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
    Introduction
    Materials and Me...
    Results
    Discussion
    Conclusion
    References
    Article Tables

 Article Access Statistics
    Viewed5281    
    Printed257    
    Emailed0    
    PDF Downloaded398    
    Comments [Add]    

Recommend this journal